Print Version
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection, 2005
Author:
CDC NCHHSTP Division of Tuberculosis Elimination, Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention, Division of Tuberculosis Elimination
Publication Date:
2011
Country of Origin:
United States
Format:
Slide Set
Language:
English
Abstract
This slide set was developed as an accompaniment to Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection, a joint statement by CDC and the American Thoracic Society, and subsequent updates. The slide set provides an overview of the current recommendations for the treatment of latent tuberculosis. The slide set also includes case studies to initiate discussion of LTBI diagnosis and treatment.Publisher:
CDC NCHHSTP Division of Tuberculosis Elimination
Audience(s):
Health Professionals
Topic:
Case Management, Diagnosis, Treatment - Latent TB infection (Inactive TB), TB Skin Test, TB Treatment, Treatment- Medication Information
Notes:
Additional LTBI information can be found on three CDC fact sheets accompanying this slide set: (1) Treatment of Latent Tuberculosis Infection: Maximizing Adherence; (2) Treatment Options for Latent Tuberculosis Infection; and (3) Targeted Tuberculin Testing and Interpreting Tuberculin Skin Test Results.
Disclaimer: The information on the Find TB Resources Website is made available as a public service. Neither the Centers for Disease Control and Prevention nor the National Prevention Information Network endorses the organizations, Website s, and materials presented. It is the responsibility of the user to evaluate this information prior to use based on individual, community, and organizational needs and standards.